This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Daguindau E, Lioure B, Buzyn A, Robin M, Faucher C, Kuentz M et al. Evidence for anti-tumour effect of allogeneic haematopoietic SCT in cases without sustained donor engraftment. Bone Marrow Transplant 2010; 45:177–180.
Au WY, Chan EC, Siu LL, Lau TC, Lie AK, Ma SK et al. Leukaemic relapse of donor origin after allogeneic bone marrow transplantation from a donor who later developed bronchogenic carcinoma. Br J Haematol 2002; 119: 777–780.
Khan F, Agarwal A, Agrawal S . Significance of chimerism in hematopoietic stem cell transplantation: new variations on an old theme. Bone Marrow Transplant 2004; 34: 1–12.
Au WY, Lie AK, Lam KY, Kwong YL . Cord blood unit deficient in glucose 6-phosphate dehydrogenase (G6PD) can preferentially engraft after double-unit unrelated cord blood transplant (UCBT) in adult. Bone Marrow Transplant 2009; 44: 57–58.
Bautista G, Cabrera JR, Regidor C, Fores R, Garcia-Marco JA, Ojeda E et al. Cord blood transplants supported by co-infusion of mobilized hematopoietic stem cells from a third-party donor. Bone Marrow Transplant 2009; 43: 365–373.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Au, WY., Lam, K., Leung, A. et al. Occult autologous haematopoietic regeneration without disease relapse following myeloablative allogeneic haematopoietic SCT for lymphomas. Bone Marrow Transplant 45, 1377–1378 (2010). https://doi.org/10.1038/bmt.2009.356
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2009.356